Exicure, Inc.
XCUR
Historically, we have been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, we announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that we were exploring strategic alternatives to maximize stockholder value.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$5M
▲ +49.0% YoY
Op. Margin
–
ROIC
-198.76%
▲ +46.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$4M
▼ -194.0% YoY
Op. Cash Flow (TTM)
-$4M
▼ -194.0% YoY
Net Debt
-$1M
Net Cash Position
Cash & Equiv.
$1M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with XCUR
Exicure (XCUR) in three numbers
Questions about Exicure
Is Exicure a high-quality business?
Exicure scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$1M, and its weakest is return on capital at -198.8%. The Quality tab shows every check against its target.
Does Exicure (XCUR) pay a dividend?
No. Exicure (XCUR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 18 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in XCUR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing XCUR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.